TOMSICEK MICHAEL JOHN has filed 5 insider transactions across 2 companies since June 2023.
Most recent transaction: a grant/award of 20275 shares of Acrivon Therapeutics, Inc. ($ACRV) on June 13, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 13, 2025 | Acrivon Therapeutics, Inc. | $ACRV | TOMSICEK MICHAEL JOHN | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 33,791,817 | 9999.99% | 0.06% |
| June 10, 2025 | Milestone Pharmaceuticals Inc. | $MIST | TOMSICEK MICHAEL JOHN | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 53,464,273 | 9999.99% | 0.07% |
| Aug. 28, 2024 | Milestone Pharmaceuticals Inc. | $MIST | TOMSICEK MICHAEL JOHN | Not found | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 53,269,565 | 9999.99% | 0.08% |
| June 20, 2024 | Acrivon Therapeutics, Inc. | $ACRV | TOMSICEK MICHAEL JOHN | Not found | A | Stock Option (Right to Buy) | 20275 | $0.00 | 20,275.0000 | 22,078,190 | 9999.99% | 0.09% |
| June 7, 2023 | Milestone Pharmaceuticals Inc. | $MIST | TOMSICEK MICHAEL JOHN | Director | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 33,357,720 | 9999.99% | 0.09% |